Related Experiment Video

Updated: Mar 31, 2026

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

9.0K

miR-320b suppresses cell proliferation by targeting c-Myc in human colorectal cancer cells

Hantao Wang1, Fuao Cao2, Xu Li3

  • 1Department of Colorectal Surgery, Changhai Hospital, Shanghai, 200433, China. hantaowang@126.com.

BMC Cancer
|October 22, 2015
PubMed
Abstract

Insights

MicroRNA-320b is down regulated in colorectal cancer (CRC) and inhibits tumor growth by targeting c-MYC. Restoring miR-320b levels offers a potential therapeutic strategy for CRC.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Background:

  • MicroRNAs (miRNAs) are crucial in tumorigenesis.
  • miR-320b is downregulated in various cancers, including colorectal cancer (CRC).
  • The precise role of miR-320b in CRC carcinogenesis is not fully understood.

Purpose of the Study:

  • To investigate the role of miR-320b in colorectal cancer (CRC) tumor growth.
  • To identify potential targets of miR-320b in CRC.

Main Methods:

  • Quantitative reverse-transcription polymerase chain reaction (qRT-PCR) to measure miR-320b expression.
  • In vitro and in vivo assays to assess the impact of miR-320b on cell proliferation.
  • Luciferase reporter assays to identify miR-320b targets.
  • Western blot and immunohistochemistry to analyze c-MYC expression.

Main Results:

  • miR-320b expression is significantly downregulated in CRC tissues and cell lines.
  • Overexpression of miR-320b inhibits CRC cell proliferation in vitro and in vivo.
  • c-MYC was identified as a direct target gene of miR-320b in CRC.
  • Increased c-MYC expression can counteract the tumor-suppressive effects of miR-320b.

Conclusions:

  • miR-320b acts as a tumor suppressor in colorectal cancer by targeting c-MYC.
  • The miR-320b/c-MYC pathway is a novel target for CRC therapy.
  • This study provides new insights into CRC pathophysiology and potential therapeutic strategies.

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.1K
Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

13.9K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
6.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K